These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 5815693

  • 21. [In vitro inhibitory effect of phenylbutazone on the hemolytic activity of complement in guinea pigs].
    Lang JM, Hainaut J.
    Agressologie; 1972; 13(2):117-20. PubMed ID: 5078837
    [No Abstract] [Full Text] [Related]

  • 22. [Studies on the effects of compound 48-80 on complement activity].
    Yamamoto S.
    Arerugi; 1969 Jan; 18(1):70-80. PubMed ID: 4181010
    [No Abstract] [Full Text] [Related]

  • 23. Complement inhibitor(s) released by leukocytes. I. Pretreatment of sheep erythrocytes with supernatants of mouse spleen and thymus cells inhibit whole complement activity and C2 utilization.
    Bernard A, Boumsell L, Borsos T, Good RA, Day NK.
    J Immunol; 1975 Oct; 115(4):1087-90. PubMed ID: 1176766
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of guinea pig complement by maleopimaric acid and other derivatives of levopimaric acid.
    Glovsky MM, Becker EL, Halbrook NJ.
    J Immunol; 1968 May; 100(5):979-90. PubMed ID: 5648478
    [No Abstract] [Full Text] [Related]

  • 25. Role of fumaropimaric acid in guinea pig complement dependent and non-complement dependent biologic reactions. I. Inhibition of Forssman, reversed passive arthus, and PCA reactions by fumaropimaric acid.
    Glovsky MM, Ward PA, Becker EL, Halbrook NJ.
    J Immunol; 1969 Jan; 102(1):1-14. PubMed ID: 4237108
    [No Abstract] [Full Text] [Related]

  • 26. Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.
    Tamura N, Nelson RA.
    J Immunol; 1967 Sep; 99(3):582-9. PubMed ID: 6051385
    [No Abstract] [Full Text] [Related]

  • 27. [C1-inactivator from guinea pig-serum mechanism of action. II. Effect of the inactivator on C1 in its bound form: EAC1, EAC14b and EAC14b2a].
    Loos M.
    Z Med Mikrobiol Immunol; 1971 Sep; 156(2):221-32. PubMed ID: 5554814
    [No Abstract] [Full Text] [Related]

  • 28. [Effect of 4-vinylpyridine and 4-vinylpyridinium oxide polymers and their copolymers on the hemolytic activity of complement].
    Ivanov AA, Gvozdetskiĭ AN, Koabanov VA.
    Dokl Akad Nauk SSSR; 1976 Sep; 229(6):1496-9. PubMed ID: 964126
    [No Abstract] [Full Text] [Related]

  • 29. Inhibition of C1s-induced vascular leakage in guinea pigs by substituted benzamidine and pyridinium compounds.
    Andrews JM, Rosen FS, Silverberg SJ, Cory M, Schneeberger EE, Bing DH.
    J Immunol; 1977 Feb; 118(2):466-71. PubMed ID: 320260
    [Abstract] [Full Text] [Related]

  • 30. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
    Bernard A, Boumsell L, Borsos.
    J Immunol; 1975 Oct; 115(4):1091-4. PubMed ID: 1176767
    [Abstract] [Full Text] [Related]

  • 31. Inactivation of the first component of human complement by m-(o-(2-chloro-5-fluorosulfonylphenylureido)-phenoxybutoxy)benzamidine.
    Bing DH, Mernitz JL, Spurlock SE.
    Biochemistry; 1972 Nov 07; 11(23):4263-8. PubMed ID: 4673057
    [No Abstract] [Full Text] [Related]

  • 32. A capillary diffusion method for determining hemolytic complement activity in undiluted serum .
    Brockman JA, Bauman N.
    J Immunol Methods; 1979 Nov 07; 27(4):353-61. PubMed ID: 469260
    [Abstract] [Full Text] [Related]

  • 33. [C1-inactivator from guinea pig serum-mechanism of action. I. Effect of the inactivator on C1 in free solution].
    Loos M, Opferkuch W, Wagner H.
    Z Med Mikrobiol Immunol; 1971 Nov 07; 156(2):208-20. PubMed ID: 4995250
    [No Abstract] [Full Text] [Related]

  • 34. Structure-activity relationships in immunochemistry. III. Inhibition of complement by benzyl pyridinium ions.
    Yoshimoto M, Hansch C, Jow PY.
    Chem Pharm Bull (Tokyo); 1975 Feb 07; 23(2):437-44. PubMed ID: 1157202
    [No Abstract] [Full Text] [Related]

  • 35. Evidence that rabbit gamma G haemolysin in capable of utilizing guinea-pig complement more efficiently than rabbit gamma M haemolysin.
    Frank MM, Gaither T.
    Immunology; 1970 Dec 07; 19(6):975-81. PubMed ID: 5487544
    [Abstract] [Full Text] [Related]

  • 36. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 Jan 07; 12(1):118-22. PubMed ID: 5763006
    [No Abstract] [Full Text] [Related]

  • 37. The effect of temperature on the reactivity of guinea-pig complement with gamma G and gamma M haemolytic antibodies.
    Frank MM, Gaither T.
    Immunology; 1970 Dec 07; 19(6):967-74. PubMed ID: 5487543
    [No Abstract] [Full Text] [Related]

  • 38. Bioeffects of the plant Mahonia sempervirens.
    Gancevici GG.
    Arch Roum Pathol Exp Microbiol; 1990 Dec 07; 49(2):183-90. PubMed ID: 2101211
    [Abstract] [Full Text] [Related]

  • 39. [Decomplementization by a factor extracted from cobra venom. Effect on several immune reactions of the guinea pig and rat].
    Maillard JL, Zarco RM.
    Ann Inst Pasteur (Paris); 1968 Jun 07; 114(6):756-74. PubMed ID: 4255485
    [No Abstract] [Full Text] [Related]

  • 40. A new complement inhibitor in guinea pig serum.
    Okada H, Kawachi S, Nishioka K.
    Jpn J Exp Med; 1969 Oct 07; 39(5):527-31. PubMed ID: 5309564
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.